R. Mathias et al., RENAL BONE-DISEASE IN PEDIATRIC AND YOUNG-ADULT PATIENTS ON HEMODIALYSIS IN A CHILDRENS-HOSPITAL, Journal of the American Society of Nephrology, 3(12), 1993, pp. 1938-1946
Renal bone disease has been well defined in adult patients receiving c
hronic dialysis and in children on peritoneal dialysis/continuous ambu
latory peritoneal dialysis. However, little is known about the histolo
gic features in patients undergoing chronic hemodialysis in a children
's hospital center. Twenty one patients, aged 17.5 +/- 1.5 yr, on hemo
dialysis for 35 +/- 6 months underwent iliac crest bone biopsies and d
eferoxamine infusion tests. Nineteen of 21 patients were receiving ora
l calcitriol. The 21 patients were classified by histomorphometry as f
ollows: osteitis fibrosa, 5; mild hyperparathyroidism, 3; normal histo
logy, 3; aplastic, 6; and mixed lesions, 4. Four of 21 patients were s
urface positive for aluminum, and seven other patients stained positiv
e for iron in bone. Serum parathyroid hormone (PTH) levels correlated
directly with the bone formation rate (r = 0.84) and with eroded bone
perimeter (r = 0.67). Eight of the nine patients with serum PTH levels
above 125 pg/mL had marrow fibrosis. All patients with serum calcium
levels <10.0 mg/dL and serum PTH levels >125 pg/mL had either osteitis
fibrosa or mixed bone lesions-a group of patients that might benefit
from aggressive vitamin D therapy. In contrast, an examination of pati
ents with serum calcium levels >10. mg/dL and serum PTH levels <65 pg/
mL correctly identified three out of three patients with aluminum-rela
ted bone disease. These findings suggest that measurements of serum in
tact PTH levels by the immunoradiometric assay method may be valuable
in distinguishing high-turnover lesions from normal or low-turnover sk
eletal lesions in this population.